HEALTHCARE GLOBAL ENTERPRISES Financial Statement Analysis
|
||
|
The Revenues of HEALTHCARE GLOBAL ENTERPRISES have increased by 16.26% YoY .
The Earnings Per Share (EPS) of HEALTHCARE GLOBAL ENTERPRISES has decreased by -7.80 % YoY. |
||
HEALTHCARE GLOBAL ENTERPRISES Last 5 Annual Financial Results
[BOM: 539787|NSE : HCG]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Operating Income | ₹2,218 Cr | ₹1,908 Cr | ₹1,691 Cr | ₹1,395 Cr | ₹1,009 Cr |
| Expenses | ₹1,836 Cr | ₹1,583 Cr | ₹1,411 Cr | ₹1,160 Cr | ₹887 Cr |
| Operating Profit (Excl OI) | ₹383 Cr | ₹325 Cr | ₹280 Cr | ₹235 Cr | ₹122 Cr |
| Other Income | ₹40 Cr | ₹21 Cr | ₹32 Cr | ₹16 Cr | ₹21 Cr |
| Interest | ₹155 Cr | ₹109 Cr | ₹104 Cr | ₹98 Cr | ₹119 Cr |
| Depreciation | ₹211 Cr | ₹174 Cr | ₹163 Cr | ₹158 Cr | ₹159 Cr |
| Profit Before Tax | ₹57 Cr | ₹68 Cr | ₹45 Cr | ₹88 Cr | ₹-229 Cr |
| Profit After Tax | ₹49 Cr | ₹41 Cr | ₹18 Cr | ₹39 Cr | ₹-221 Cr |
| Consolidated Net Profit | ₹44 Cr | ₹48 Cr | ₹29 Cr | ₹54 Cr | ₹-193 Cr |
| Earnings Per Share (Rs) | ₹3.19 | ₹3.46 | ₹2.11 | ₹3.87 | ₹-15.43 |
| PAT Margin (%) | 2.20 | 2.17 | 1.04 | 2.79 | -21.91 |
| ROE(%) | 5.72 | 4.99 | 2.06 | 5.16 | -43.32 |
| ROCE(%) | 12.36 | 12.79 | 11.69 | 15.17 | -9.66 |
| Total Debt/Equity(x) | 1.11 | 0.83 | 0.47 | 0.47 | 0.73 |
Key Financials |
||
| Market Cap | : | ₹ 8,343.7 Cr |
| Revenue (TTM) | : | ₹ 2,403.7 Cr |
| Net Profit(TTM) | : | ₹ 39.4 Cr |
| EPS (TTM) | : | ₹ 2.8 |
| P/E (TTM) | : | 212.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HEALTHCARE GLOBAL ENTERPRISES | -4.2% | -11.1% | 14.9% |
| MAX HEALTHCARE INSTITUTE | -3.5% | -8.1% | -9.6% |
| APOLLO HOSPITALS ENTERPRISE | 2.3% | -0.4% | 0.9% |
| FORTIS HEALTHCARE | 1% | -3.1% | 36.7% |
| GLOBAL HEALTH | 2.4% | -8.5% | -1.2% |
| NARAYANA HRUDAYALAYA | 1.1% | -3.4% | 33.6% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 3.7% | 0.4% | -0.1% |
| DR LAL PATHLABS | 2.4% | -3.3% | -1.3% |
| ASTER DM HEALTHCARE | -0.4% | -9.5% | 9% |
HEALTHCARE GLOBAL ENTERPRISES Revenues
[BOM: 539787|NSE : HCG]
| Y-o-Y | 16.26 % |
| 5 Yr CAGR | 21.76 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,218 Cr | 16.26 | |
| Mar2024 | ₹1,908 Cr | 12.80 | |
| Mar2023 | ₹1,691 Cr | 21.27 | |
| Mar2022 | ₹1,395 Cr | 38.21 | |
| Mar2021 | ₹1,009 Cr | - | |
HEALTHCARE GLOBAL ENTERPRISES Operating Profit
[BOM: 539787|NSE : HCG]
| Y-o-Y | 17.59 % |
| 5 Yr CAGR | 32.98 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹383 Cr | 17.59 | |
| Mar2024 | ₹325 Cr | 16.09 | |
| Mar2023 | ₹280 Cr | 19.27 | |
| Mar2022 | ₹235 Cr | 92.07 | |
| Mar2021 | ₹122 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 1.17 % |
| 5 Yr CAGR | 9.22 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 17.25% | 1.17 | |
| Mar2024 | 17.05% | 2.90 | |
| Mar2023 | 16.57% | -1.66 | |
| Mar2022 | 16.85% | 39.03 | |
| Mar2021 | 12.12% | - | |
HEALTHCARE GLOBAL ENTERPRISES Profit After Tax
[BOM: 539787|NSE : HCG]
| Y-o-Y | -7.78 % |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹44 Cr | -7.78 | |
| Mar2024 | ₹48 Cr | 64.08 | |
| Mar2023 | ₹29 Cr | -45.38 | |
| Mar2022 | ₹54 Cr | Positive | |
| Mar2021 | ₹-193 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 1.38 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 2.2 % | 1.38 | |
| Mar2024 | 2.17 % | 108.65 | |
| Mar2023 | 1.04 % | -62.72 | |
| Mar2022 | 2.79 % | Positive | |
| Mar2021 | -21.91 % | - | |
HEALTHCARE GLOBAL ENTERPRISES Earnings Per Share (EPS)
[BOM: 539787|NSE : HCG]
| Y-o-Y | -7.80 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.19 | -7.80 | |
| Mar2024 | ₹3.46 | 63.98 | |
| Mar2023 | ₹2.11 | -45.48 | |
| Mar2022 | ₹3.87 | Positive | |
| Mar2021 | ₹-15 | - | |
HEALTHCARE GLOBAL ENTERPRISES Return on Capital Employed (ROCE)
[BOM: 539787|NSE : HCG]
| Y-o-Y | -3.36 % |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 12.36% | -3.36 | |
| Mar2024 | 12.79% | 9.41 | |
| Mar2023 | 11.69% | -22.94 | |
| Mar2022 | 15.17% | Positive | |
| Mar2021 | -9.66% | - | |
HEALTHCARE GLOBAL ENTERPRISES Share Price vs Sensex
| Current Share Price | : | ₹591.8 |
| Current MarketCap | : | ₹ 8,343.7 Cr |
| Updated EOD on | : | Jan 30,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HEALTHCARE GLOBAL ENTERPRISES | -4.2% |
-11.1% |
14.9% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
HEALTHCARE GLOBAL ENTERPRISES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | -1.1% | -5.2% | -4.2% |
| BSE SMALLCAP | -5.8% | -8.9% | -10.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MICROCAP 250 | 1.4% | -4.4% | -8.4% |
| NIFTY TOTAL MARKET | 0.4% | -2.6% | 6.5% |
You may also like the below Video Courses
FAQ about HEALTHCARE GLOBAL ENTERPRISES Financials
How the annual revenues of HEALTHCARE GLOBAL ENTERPRISES have changed ?
The Revenues of HEALTHCARE GLOBAL ENTERPRISES have increased by 16.26% YoY .
How the Earnings per Share (EPS) of HEALTHCARE GLOBAL ENTERPRISES have changed?
The Earnings Per Share (EPS) of HEALTHCARE GLOBAL ENTERPRISES has decreased by -7.80 % YoY .
Check out Intrinsic Value of Peers of HEALTHCARE GLOBAL ENTERPRISES
Compare Stock Analytics of Peers of HEALTHCARE GLOBAL ENTERPRISES
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
